December 2014 – Study published in Reproductive Toxicology concludes that use of Zofran during the 1st trimester of pregnancy correlates with a “increased and statistically significant” increased risk of cardiovascular birth defects.
December 2014 – Study published in Reproductive Toxicology concludes that use of Zofran during the 1st trimester of pregnancy correlates with a “increased and statistically significant” increased risk of cardiovascular birth defects.